| BrCa | Bil. BrCa | OvCa | BrCa and OvCa | Non-affected |
---|---|---|---|---|---|
Number of index individuals (n = 82) | 57 | 8 | 1 | 5 | 11 |
Age at diagnosis | Â | Â | Â | Â | Â |
(BrCa/OvCa) | n = 57 | n = 16a | n = 1 | n = 10b | - |
<30 | 13 | 0 | 0 | 1 | - |
<40 years | 11 | 2 | 0 | 2 | - |
<50 years | 15 | 7 | 0 | 2 | - |
≥50 years | 18 | 7 | 1 | 5 | - |
Type of BrCa | n = 57 | n = 16a | - | n = 5 | - |
Ductal | 41 | 8 | - | 5 | - |
Intraductal | 2 | 2 | - | 0 | - |
Lobular | 9 | 3 | - | 0 | - |
Papillary | 1 | 0 | - | 0 | - |
Medullary | 1 | 0 | - | 0 | - |
Unknown | 3 | 3 | - | 0 | - |
Ductal carcinomas grade known | n = 38 | n = 6 | Â | n = 5 | - |
Grade 1 | 7 | 3 | Â | 0 | - |
Grade 2 | 14 | 3 | Â | 3 | - |
Grade 3 | 17 | 0 | Â | 2 | - |
ER status known | n = 51 | n = 11 | - | n = 4 | - |
ER + | 35 | 10 | - | 2 | - |
ER- | 16 | 1 | - | 2 | - |
PR status known | n = 50 | n = 11 | - | n = 4 | - |
PR+ | 30 | 10 | - | 2 | - |
PR- | 20 | 1 | - | 2 | - |
HER2, status known | n = 46 | n = 11 | - | n = 4 | - |
HER2+ | 14 | 1 | - | 1 | - |
HER2- | 32 | 10 | - | 3 | - |
Type of OvCa | - | - | n = 1 | n = 5 | - |
Serous | - | - | 0 | 0 | - |
Endometrioid | - | - | 0 | 0 | - |
Mucinous | - | - | 0 | 2 | - |
Clear cell | - | - | 0 | 1 | - |
Other | - | - | 0 | 2 | - |
Unknown | - | - | 1 | 0 | - |
Number of affected (BrCa/OvCa) | Â | Â | Â | Â | Â |
first-degree relatives | n = 57 | n = 8 | n = 1 | n = 5 | n = 11 |
≥2 | 25 | 3 | 1 | 0 | 5 |
≥1 | 24 | 4 | 0 | 0 | 6 |
0 | 8 | 1 | 0 | 5 | 0 |
Number of affected (BrCa/OvCa) | Â | Â | Â | Â | Â |
second-degree relatives | n = 57 | n = 8 | n = 1 | n = 5 | n = 11 |
≥2 | 5 | 0 | 0 | 0 | 4 |
≥1 | 11 | 1 | 0 | 0 | 0 |
0 | 41 | 7 | 1 | 5 | 7 |